In addition, AT1R antagonist also prevented gastric cancer progression by blocking the angiotensin II-induced overexpression of matrix metallopeptidase-2 (MMP-2) and MMP-9, critical components mediating tumor migration and invasion [93]. The gene discussed is AGT; the disease is neoplasm.